< Go back

IceCure shares first published results using the Prosense cryoablation system in kidney cancer

“None of the treated tumor lesions demonstrated contrast enhancement or growth on follow up imaging indicating a 100% oncologic success.”

The full research was published in the Journal of Molecular and Clinical Medicine and conducted by Bnai Zion Medical Center in Israel by Dr. Sagi Shprits, Dr. Robert Sachner, Prof Ofer Nativ and Dr Sarel Halachmi.

Read the full clinical research paper here.